Related Experiment Videos
Scintigraphy in a patient with complicated osteopetrosis
1Department of Nuclear Medicine, Groote Schuur Hospital, Cape Town, South Africa.
Clinical Nuclear Medicine
|May 1, 1989
Summary
This study details imaging findings in osteopetrosis, revealing abnormal bone metabolism, absent bone marrow activity, and enlarged spleen impacting kidney function. These nuclear medicine scans highlight the systemic effects of this rare genetic bone disorder.
Area of Science:
- Nuclear Medicine
- Radiology
- Genetics
Background:
- Osteopetrosis is a rare genetic disorder characterized by impaired osteoclast function, leading to increased bone density.
- Diagnosis and management require comprehensive imaging to assess systemic involvement.
Observation:
- Nuclear medicine imaging was performed using Technetium-99m methylene diphosphonate (Tc-99m MDP), Technetium-99m human serum albumin (Tc-99m HSA) millimicrospheres, and Technetium-99m diethylene triamine pentaacetic acid (Tc-99m DTPA).
- Skeletal scintigraphy showed increased radiotracer uptake at fracture sites, the frontal bone, and splayed metaphyses.
- Reticuloendothelial imaging revealed absent bone marrow activity, hepatosplenomegaly, and extramedullary hematopoiesis.
- Renal scintigraphy demonstrated a left kidney displaced and distorted by splenomegaly.
Findings:
- The bone scan indicated widespread metabolic abnormalities and fractures.
- Reticuloendothelial scans highlighted the shift of hematopoiesis from bone marrow to extramedullary sites.
- Renal imaging confirmed the significant mass effect of the enlarged spleen.
Implications:
- These findings underscore the utility of multi-modality nuclear imaging in evaluating the complex manifestations of osteopetrosis.
- Understanding these imaging patterns is crucial for patient management and monitoring disease progression.
- This case illustrates the extraskeletal complications associated with osteopetrosis, particularly extramedullary hematopoiesis and its impact on adjacent organs.